In this short blog, Sarah Chapman looks at the evidence on treatments for vaginal thrush and what else might matter to you when looking for a treatment for it.

The evidence comes from three Cochrane Reviews by the Sexually Transmitted Infections Group* and is relevant to women with vaginal thrush, except women who are HIV positive, immunocompromised, pregnant, breastfeeding or have diabetes, as the research studies excluded them.

Read the full blog on the Evidently Cochrane blog page. 

*The evidence comes from these Cochrane Reviews:

- Cooke G, Watson C, Deckx L, Pirotta M, Smith J, van Driel ML. Treatment for recurrent vulvovaginal candidiasis (thrush). Cochrane Database of Systematic Reviews 2022, Issue 1. Art. No.: CD009151

- Denison HJ, Worswick J, Bond CM, Grimshaw JM, Mayhew A, Gnani Ramadoss S, Robertson C, Schaafsma ME, Watson MC. Oral versus intra-vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database of Systematic Reviews 2020, Issue 8. Art. No.: CD002845

- Xie HY, Feng D, Wei DM, Mei L, Chen H, Wang X, Fang F. Probiotics for vulvovaginal candidiasis in non-pregnant women. Cochrane Database of Systematic Reviews 2017, Issue 11. Art. No.: CD010496